\-\ Texto\\:\\ \ \(0\)\
\-\ this\\ is\\ a\\ normal\\ finding\ \(0\)\
\-\ f\\-18\\ fdg\\ pet\\/ct\\ images\\ demonstrate\\ bilateral\\ symmetric\\ hypermetabolism\\ in\\ the\\ supraclavicular\\ region\\ which\\ on\\ ct\\ scan\\ correlates\\ with\\ low\\ attenuation\\ areas\\ consistent\\ with\\ fat\\.\ \(0\)\
\-\ supraclavicular\\ brown\\ fat\ \(1\)\
\-\ supraclavicular\\ lymph\\ node\\ metastasis\ \(0\)\
\-\ benign\\ uptake\\ in\\ muscle\\ due\\ to\\ tension\ \(0\)\
\-\ benign\\ supraclavicular\\ brown\\ fat\\ metabolism\ \(0\)\
\-\ 55\\ year\\ old\\ female\\ patient\\ with\\ a\\ diagnosis\\ of\\ hepatocellular\\ carcinoma\\.\\ f\\-18\\ fdg\\ pet\\/ct\\ scan\\ for\\ staging\\/evaluation\\.\ \(0\)\
\-\ the\\ ability\\ to\\ recognize\\ brown\\ fat\\ hypermetabolism\\ is\\ critical\\ in\\ evaluating\\ pet\\ scans\\.\\ this\\ is\\ a\\ normal\\ finding\\ and\\ should\\ not\\ be\\ confused\\ with\\ metastatic\\ disease\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ brown\\:\\ 0\\.17617076855057975\ \(0\)\
\-\ supraclavicular\\:\\ 0\\.1643803238274089\ \(0\)\
\-\ hypermetabolism\\:\\ 0\\.1607688778187164\ \(0\)\
\-\ \\-benign\\:\\ 0\\.15477550130930431\ \(0\)\
\-\ f\\-18\\:\\ 0\\.14311683906064968\ \(0\)\
\-\ pet\\/ct\\:\\ 0\\.12723892130967265\ \(0\)\
\-\ fdg\\:\\ 0\\.1157796226238545\ \(0\)\
\-\ fat\\:\\ 0\\.10828801345340139\ \(0\)\
\-\ \\-supraclavicular\\:\\ 0\\.09182831691631768\ \(0\)\
\-\ staging\\/evaluation\\:\\ 0\\.09182831691631768\ \(0\)\
\-\ recognize\\:\\ 0\\.061720277771565975\ \(0\)\
\-\ correlates\\:\\ 0\\.05788981131192725\ \(0\)\
\-\ metabolism\\:\\ 0\\.05788981131192725\ \(0\)\
\-\ tension\\:\\ 0\\.05749668289543926\ \(0\)\
\-\ finding\\:\\ 0\\.05737628135496836\ \(0\)\
\-\ critical\\:\\ 0\\.055406363151041846\ \(0\)\
\-\ ability\\:\\ 0\\.054214588659607016\ \(0\)\
\-\ confused\\:\\ 0\\.05264914904450974\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.051288522144331994\ \(0\)\
\-\ scan\\:\\ 0\\.04983898875902038\ \(0\)\
\-\ evaluating\\:\\ 0\\.04953203555645916\ \(0\)\
\-\ pet\\:\\ 0\\.04671651128833507\ \(0\)\
\-\ 55\\:\\ 0\\.043153016557339496\ \(0\)\
\-\ scans\\:\\ 0\\.041450380385573124\ \(0\)\
\-\ node\\:\\ 0\\.04073170464091738\ \(0\)\
\-\ symmetric\\:\\ 0\\.040654828523233814\ \(0\)\
\-\ lymph\\:\\ 0\\.035932733426506734\ \(0\)\
\-\ attenuation\\:\\ 0\\.03578771948360457\ \(0\)\
\-\ uptake\\:\\ 0\\.03536441067389804\ \(0\)\
\-\ metastasis\\:\\ 0\\.03332028464895757\ \(0\)\
\-\ muscle\\:\\ 0\\.031972033681524424\ \(0\)\
\-\ areas\\:\\ 0\\.029951533033813194\ \(0\)\
\-\ should\\:\\ 0\\.028377172311341667\ \(0\)\
\-\ normal\\:\\ 0\\.02790859280414794\ \(0\)\
\-\ carcinoma\\:\\ 0\\.02522841322933194\ \(0\)\
\-\ region\\:\\ 0\\.025141679450409505\ \(0\)\
\-\ low\\:\\ 0\\.024751750550691662\ \(0\)\
\-\ due\\:\\ 0\\.02375288700992541\ \(0\)\
\-\ metastatic\\:\\ 0\\.022407389621000938\ \(0\)\
\-\ consistent\\:\\ 0\\.021826023633658365\ \(0\)\
\-\ bilateral\\:\\ 0\\.021602268013692125\ \(0\)\
\-\ demonstrate\\:\\ 0\\.02048387647221917\ \(0\)\
\-\ diagnosis\\:\\ 0\\.020439784695629373\ \(0\)\
\-\ this\\:\\ 0\\.020023691944044436\ \(0\)\
\-\ female\\:\\ 0\\.018299586160914934\ \(0\)\
\-\ is\\:\\ 0\\.017571586824522676\ \(0\)\
\-\ images\\:\\ 0\\.017075665541139103\ \(0\)\
\-\ which\\:\\ 0\\.016616089450443215\ \(0\)\
\-\ disease\\:\\ 0\\.014549349387663585\ \(0\)\
\-\ be\\:\\ 0\\.013726632534832594\ \(0\)\
\-\ in\\:\\ 0\\.013168663441882967\ \(0\)\
\-\ not\\:\\ 0\\.012862694497311826\ \(0\)\
\-\ ct\\:\\ 0\\.01245107972283378\ \(0\)\
\-\ a\\:\\ 0\\.01239374380683129\ \(0\)\
\-\ year\\:\\ 0\\.009959429888259527\ \(0\)\
\-\ old\\:\\ 0\\.009113902050648486\ \(0\)\
\-\ patient\\:\\ 0\\.008922832613712375\ \(0\)\
\-\ to\\:\\ 0\\.00889725225922888\ \(0\)\
\-\ for\\:\\ 0\\.007594876548361615\ \(0\)\
\-\ on\\:\\ 0\\.007540531378806542\ \(0\)\
\-\ with\\:\\ 0\\.004875174003745405\ \(0\)\
\-\ the\\:\\ 0\\.0028801934313255374\ \(0\)\
\-\ and\\:\\ 0\\.0018750938097106089\ \(0\)\
\-\ \\.\\:\\ 0\\.0018489341717367852\ \(0\)\
\-\ of\\:\\ 0\\.0012135812583123793\ \(0\)\
